Conatus Pharmaceuticals Inc. (CNAT)


Conatus Pharmaceuticals Inc. (CNAT)

$0.32 USD

0.00 (0.00%)

Updated Aug 20 4:00pm

Add CNAT to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 329 in Biotech

See all “A” rated Strong Buy stocks

CNAT Daily Price Range
CNAT 52-Week Price Range

CNAT Stock Chart More Charts


CNAT Price/Volume Stats

Current price $0.32
Prev. close $0.32
Day low $0.30
Day high $0.33
50-day MA $0.42
200-day MA $1.62
52-week high $6.74
52-week low $0.25
Volume 320,991
Avg. volume 934,384
Dividend yield N/A
Market Cap 10.61M

Conatus Pharmaceuticals Inc. (CNAT) Company Bio


Conatus Pharmaceuticals Inc., a biotechnology company, focuses on the development and commercialization of novel medicines to treat liver diseases in the United States. The company was founded in 2005 and is based in San Diego, California.





CNAT News Stream


Event/Time News Detail
Loading, please wait...

CNAT Social Stream


Loading social stream, please wait...

View Full CNAT Social Stream

CNAT Returns

1-mo -0.65%
3-mo -62.28%
6-mo -83.07%
1-year -91.98%
3-year -83.25%
5-year -94.90%
YTD -81.50%
2018 -62.55%
2017 -12.33%
2016 82.99%
2015 -58.86%
2014 8.53%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.4393 seconds.